Project detail - ELZ SAGLIK YATIRIM A.S.

ELZ SAGLIK YATIRIM A.S.

Status: Approved investment
Back to map

Why disclosure?

FMO is committed to making publicly available relevant investment information that informs stakeholders and enables them to engage directly with FMO on its investments which, in turn, enhances our investment decisions, the design and implementation of projects and policies, and strengthens development outcomes. Learn more

In case of questions

In case of questions, please contact us at disclosure@fmo.nl

Disclaimer

The information as disclosed is indicative and provided on an "as-is/as available" basis for general informational purposes only and should not be construed as financial, legal or investment advice, nor as a commitment or an offer to arrange or provide any financing. The final decision to provide financing is subject to the terms and conditions of FMO in its sole and absolute discretion. When providing links to other sites, FMO bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. The information on proposed investment for high-risk investments is made available in the language relevant to the country or region where the bulk of operations take place. Translations of any information into languages other than English are intended as a convenience for local stakeholders. In case of any discrepancy, the information provided in English will prevail.

Who is our customer

The sponsors of the project are Ronesans Saglik Yatirimlari and Ronesans Holding (44 percent), Meridiam Infrastructure Fund (36 percent) and Sila Group, TTT, Sam Yapi (20 percent). Ronesans is one of the top international construction contractors with track record in emerging markets, while Meridiam is an experienced financial sponsor with track record of bidding and implementing major infrastructure projects. Sila, TTT and Sam Yapi provide strong expertise and know-how of the public and private Turkish healthcare market.

What is our funding objective?

ELZ is an SPV that is established by the consortium to build, finance and maintain an integrated health campus with 1,038 beds in Elazig, Turkey for an operation period of 25 years following a construction period of 3 years.

Why do we fund this investment?

The project addresses lower quality and inefficient healthcare services in Elazig, Turkey. At present, nation-wide provision of hospital beds is low (currently 2.6 beds/ 1000 people vs 4.8 beds/ 1000 people in the OECD), and hospital space per bed is limited (currently 55m2 vs 175 m2 in line with international standards) in Turkey. Furthermore, the proposed transaction fits with FMO's strategy since FMO finances a "green" hospital in a UMIC country: as confirmed by the second party opinion of Vigeo. Additionally, FMO stimulates private sector in healthcare which is traditionally state-dominated: as private sector will provide 19 different services during the operation period of 25 years under the concession. e.g. supply of medical equipment and clinical support services such as laboratory/ imaging/ sterilization services, furnishing/ maintenance/ repair of the facilities, waste management, catering, linen and laundry services, security services. Hence, the project entails more than only real-estate development, with substantial job creation impacts (during construction 3,200 direct and 300 indirect jobs supported under EPC contracts,during operation period more than 3,800 direct and indirect jobs supported under O&M contracts). FMO derives additionality through stamp of approval and long-term financing for one of the major PPP projects in Turkey: FMO derives its additionality by boosting investor confidence weakened after the recent turmoil in the country. FMO contributes to one of the first healthcare PPP projects of the country where the legal infrastructure took nearly 8 years to develop.

Website customer/investment
http://www.pppelazighastanesi.com/en
Region
Europe & Central Asia
Country
Türkiye
Sector
Infrastructure, Manufacturing and Services
Effective date
12/6/2016
Total FMO financing
EUR 20.00 MLN
Funding
FMO NV
Risk categorization on environmental and social impacts, A = high risk, B+ = medium high risk, B = medium risk, C = low risk Environmental & Social Category
(A, B+, B or C)
B